Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Cytokinetics (CYTK)

Cytokinetics: Chief Accounting Officer Robert Wong to depart December 31, 2024

Neutral Impact 2 of 5 leadership Written later

Cytokinetics said its Chief Accounting Officer, Robert Wong, will leave the company effective December 31, 2024, and that there is no disagreement with him on financial condition or reporting. Chief Financial Officer Sung Lee, who joined in May 2024, will also take on the role of principal accounting officer when Wong departs, so the change is administrative and does not add a new executive.

Key points

  • Robert Wong, Chief Accounting Officer and principal accounting officer, departs effective December 31, 2024
  • Sung Lee, CFO since May 2024, will additionally serve as principal accounting officer upon Wong's departure
  • Filing states no disagreement between Wong and the company on financial condition or financial reporting

The filing

CompanyCytokinetics (CYTK)
Form8-K, current report
Filed with the SECDec 16, 2024, 4:38 PM ET
Accession number0000950170-24-136695

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 16, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.